Currently available preliminary results of the CAIRO4 RCT suggest that patients who had elevated serum levels of lactate dehydrogenase, aspartate transaminase, alanine aminotransferase, and/or leukocytosis who were randomized to PTR had a significantly higher 60-day mortality than patients without these conditions10. The gene discussed is GPT; the disease is Increased total leukocyte count.